Literature DB >> 14517148

The metabolic syndrome: a practical guide to origins and treatment: Part II.

Peter W F Wilson1, Scott M Grundy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14517148     DOI： 10.1161/01.CIR.0000089506.12223.F1

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

1.  Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.

Authors:  Arwa Younis; Anan Younis; Boaz Tzur; Yael Peled; Nir Shlomo; Ilan Goldenberg; Enrique Z Fisman; Alexander Tenenbaum; Robert Klempfner
Journal:  Cardiovasc Diabetol       Date:  2016-10-28       Impact factor: 9.951

2.  Nontraditional serum lipid variables and recurrent stroke risk.

Authors:  Jong-Ho Park; Juneyoung Lee; Bruce Ovbiagele
Journal:  Stroke       Date:  2014-09-18       Impact factor: 7.914

Review 3.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Authors:  H J Teede; S Hutchison; S Zoungas; C Meyer
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

4.  Metabolic profile and psychological variables after bariatric surgery: association with weight outcomes.

Authors:  Isabel Brandão; Sofia Ramalho; Ana Pinto-Bastos; Filipa Arrojado; Gil Faria; Conceição Calhau; Rui Coelho; Eva Conceição
Journal:  Eat Weight Disord       Date:  2015-06-28       Impact factor: 4.652

Review 5.  Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.

Authors:  Naveen Sharma; Isidore C Okere; Monika K Duda; David J Chess; Karen M O'Shea; William C Stanley
Journal:  Cardiovasc Res       Date:  2006-11-11       Impact factor: 10.787

6.  Hyperinsulinemia predisposes to NAFLD.

Authors:  Sandhya Mishra; Dharamveer Yadav; Monika Gupta; Hemant Mishra; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2008-06-11

7.  PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome.

Authors:  Hong Chen; Abul Fajol; Miriam Hoene; Bingbing Zhang; Erwin D Schleicher; Yun Lin; Carsten Calaminus; Bernd J Pichler; Cora Weigert; Hans U Häring; Florian Lang; Michael Föller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

8.  Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial.

Authors:  C A Daly; P Hildebrandt; M Bertrand; R Ferrari; W Remme; M Simoons; K M Fox
Journal:  Heart       Date:  2007-05-31       Impact factor: 5.994

9.  Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain.

Authors:  Itziar Lamiquiz-Moneo; Cristian Blanco-Torrecilla; Ana M Bea; Rocío Mateo-Gallego; Sofía Pérez-Calahorra; Lucía Baila-Rueda; Ana Cenarro; Fernando Civeira; Isabel de Castro-Orós
Journal:  Lipids Health Dis       Date:  2016-04-23       Impact factor: 3.876

Review 10.  Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndrome.

Authors:  Thomas D Giles; Gary E Sander
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-11       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.